Antoine Drevelle
Bordeaux, Nouvelle-Aquitaine, France
2 k abonnés
+ de 500 relations
À propos
With over two decades of professional experience, my role as CEO at Kapsera reflects my…
Activité
-
Check this out: I am recruiting a manager for my team of High-Throughput Screening (HTS). Don't miss this opportunity and join us for working…
Check this out: I am recruiting a manager for my team of High-Throughput Screening (HTS). Don't miss this opportunity and join us for working…
Aimé par Antoine Drevelle
-
🌱 𝗔𝗕𝗜𝗠 𝟮𝟬𝟮𝟱, 𝗰’𝗲𝘀𝘁 𝗽𝗮𝗿𝘁𝗶 ! Aujourd’hui, Antofénol est à Bâle en Suisse pour la 𝟮𝟬ᵉ 𝗲́𝗱𝗶𝘁𝗶𝗼𝗻 de l’Annual Biocontrol…
🌱 𝗔𝗕𝗜𝗠 𝟮𝟬𝟮𝟱, 𝗰’𝗲𝘀𝘁 𝗽𝗮𝗿𝘁𝗶 ! Aujourd’hui, Antofénol est à Bâle en Suisse pour la 𝟮𝟬ᵉ 𝗲́𝗱𝗶𝘁𝗶𝗼𝗻 de l’Annual Biocontrol…
Aimé par Antoine Drevelle
Expérience
Formation
-
Université Paris Sud (Paris XI)
-
-
Diplôme incluant :
2003 D.E.A. « Structure, Fonction et Ingénierie des Protéines » option Enzymologie Moléculaire
et Biocatalyse - Université Paris-Sud Orsay - mention Bien - Bourse au mérite de 3ème cycle.
2002 Maîtrise de biochimie - Université Paris-Sud Orsay - mention Bien.
2001 Licence de biochimie - Université Paris-Sud Orsay - mention Très Bien. -
-
-
Publications
-
Disulfide bonds substitution by directed evolution in an engineered binding protein
Chembiochem
Voir la publicationThe antitumour protein, neocarzinostatin (NCS), is one of the few drug-carrying proteins used in human therapeutics. However, the presence of disulfide bonds limits this protein's potential development for many applications. This study describes a generic directed-evolution approach starting from NCS-3.24 (shown in the figure complexed with two testosterone molecules) to engineer stable disulfide-free NCS variants suitable for a variety of purposes, including intracellular applications.The…
The antitumour protein, neocarzinostatin (NCS), is one of the few drug-carrying proteins used in human therapeutics. However, the presence of disulfide bonds limits this protein's potential development for many applications. This study describes a generic directed-evolution approach starting from NCS-3.24 (shown in the figure complexed with two testosterone molecules) to engineer stable disulfide-free NCS variants suitable for a variety of purposes, including intracellular applications.The chromoprotein neocarzinostatin (NCS) has been intensively studied for its antitumour properties. It has recently been redesigned as a potential drug-carrying scaffold. A potential limit of this protein scaffold, especially for intracellular applications, is the presence of disulfide bonds. The objective of this work was to create a disulfide-free NCS-derived scaffold. A generic targeted approach was developed by using directed evolution methods. As a starting point we used a previously engineered NCS variant in which a hapten binding site had been created. A library was then generated in which cysteine Cys88 and Cys93 and neighbouring residues were randomly substituted. Variants that preserved the hapten binding function were selected by phage display and further screened by colony filtration methods. Several sequences with common features emerged from this process. The corresponding proteins were expressed, purified and their biophysical properties characterised. How these selected sequences rescued folding ability and stability of the disulfide-free protein was carefully examined by using calorimetry and the results were interpreted with molecular simulation techniques.
-
Structures of in vitro evolved binding sites on neocarzinostatin scaffold reveal unanticipated evolutionary pathways.
Journal of Molecular Biology
Voir la publicationWe have recently applied in vitro evolution methods to create in Neocarzinostatin a new binding site for a target molecule unrelated to its natural ligand. The main objective of this work was to solve the structure of some of the selected binders in complex with the target molecule: testosterone. Three proteins (1a.15, 3.24 and 4.1) were chosen as representative members of sequence families that came out of the selection process within different randomization schemes. In order to evaluate…
We have recently applied in vitro evolution methods to create in Neocarzinostatin a new binding site for a target molecule unrelated to its natural ligand. The main objective of this work was to solve the structure of some of the selected binders in complex with the target molecule: testosterone. Three proteins (1a.15, 3.24 and 4.1) were chosen as representative members of sequence families that came out of the selection process within different randomization schemes. In order to evaluate ligand-induced conformational adaptation, we also determined the structure of one of the proteins (3.24) in the free and complexed forms. Surprisingly, all these mutants bind not one but two molecules of testosterone in two very different ways. The 3.24 structure revealed that the protein spontaneously evolved in the system to bind two ligand molecules in one single binding crevice. These two binding sites are formed by substituted as well as by non-variable side-chains. The comparison with the free structure shows that only limited structural changes are observed upon ligand binding. The X-ray structures of the complex formed by 1a.15 and 4.1 Neocarzinostatin mutants revealed that the two variants form very similar dimers. These dimers were observed neither for the uncomplexed variants nor for wild-type Neocarzinostatin but were shown here to be induced by ligand binding. Comparison of the three complexed forms clearly suggests that these unanticipated structural responses resulted from the molecular arrangement used for the selection experiments.
Brevets
-
Nouveaux substrats fluorescents, procédé d'obtention de ces produits et leur application
Émis le FR WO2012038614 (A1)
L'invention concerne de nouveaux substrats fluorescents, leur procédé d'obtention ainsi que leur application. Ces nouveaux substrats résultent d'un greffage d'un dérivé fluoré d'une coumarine sulfonatée, également dénommé fluorophore, sur un sucre choisi parmi les sucres suivants : cellobiose, xylobiose, maltose, saccharose, glucose, xylose, galactose, arabinose, xylane, glucane, xylotriose, maltotriose, cellotriose. Le procédé de greffage consiste essentiellement en une bromation du sucre dont…
L'invention concerne de nouveaux substrats fluorescents, leur procédé d'obtention ainsi que leur application. Ces nouveaux substrats résultent d'un greffage d'un dérivé fluoré d'une coumarine sulfonatée, également dénommé fluorophore, sur un sucre choisi parmi les sucres suivants : cellobiose, xylobiose, maltose, saccharose, glucose, xylose, galactose, arabinose, xylane, glucane, xylotriose, maltotriose, cellotriose. Le procédé de greffage consiste essentiellement en une bromation du sucre dont les groupements hydroxyles ont été protégés, en le greffage proprement dit du fluorophore sur le sucre ainsi protégé et bromé, et en la déprotection des fonctions acétates du substrat, diverses purifications pouvant en outre être intégrées au procédé. Application à la détection d'activités glycoside hydrolases ou glycosidases sur des extraits enzymatiques purifiés ou non ou sur des microorganismes.
Autres inventeurs -
Plus d’activités de Antoine
-
Looking forward to fruitful exchanges on Solyve booth!
Looking forward to fruitful exchanges on Solyve booth!
Aimé par Antoine Drevelle
-
🌱 Excited to attend the ABIM - Annual Biocontrol Industry Meeting in Basel with Kapsera! With Nicolas LECERF and Lorena Sanchez, we’re looking…
🌱 Excited to attend the ABIM - Annual Biocontrol Industry Meeting in Basel with Kapsera! With Nicolas LECERF and Lorena Sanchez, we’re looking…
Partagé par Antoine Drevelle
-
🌱 When innovation meets sustainability, the impact can be transformative. Today, we had the pleasure of visiting Zymofix, an inspiring start-up…
🌱 When innovation meets sustainability, the impact can be transformative. Today, we had the pleasure of visiting Zymofix, an inspiring start-up…
Aimé par Antoine Drevelle
-
🌱 Great opportunity at Kapsera! We’re looking for a Business Developer in Nutrition to join our growing team at Kapsera 🚀 If you’re passionate…
🌱 Great opportunity at Kapsera! We’re looking for a Business Developer in Nutrition to join our growing team at Kapsera 🚀 If you’re passionate…
Partagé par Antoine Drevelle